J&J eyes 1 billion doses of potential COVID-19 shot in 2021, weighs challenge trials

BRUSSELS: Johnson & Johnson could produce 1 billion doses of its potential COVID-19 vaccine next year if it proves successful and would consider injecting healthy volunteers with the novel coronavirus if there are not enough patients for final trials, a company executive said.

J&J kicked off in ...
---
[rating]
[rating-type-1]
{rating}
[/rating-type-1] [rating-type-2]
[rating-plus] {rating} [/rating-plus]
[/rating-type-2] [rating-type-3]
[rating-plus][/rating-plus] {rating} [rating-minus][/rating-minus]
[/rating-type-3]
[/rating]
  • 0
  • [com-link] 0[/com-link]